Mendeley出力
＜博士論文＞
胃癌腹膜播種関連遺伝子ADP ribosylation factor like 4c（ARL4C）の同定とその臨床的及び生物学的意義
| 作成者 | |
|---|---|
| 論文調査委員 | |
| 本文言語 | |
| 学位授与年度 | |
| 学位授与大学 | |
| 学位 | |
| 学位種別 | |
| アクセス権 | |
| 関連DOI | |
| 概要 | BACKGROUND:In gastric cancer (GC), peritoneal dissemination (PD) occurs frequently and is incurable. In this study, we aimed to identify PD-associated genes in GC. METHODS:We identified a PD-associated... gene using three GC datasets: highly disseminated peritoneal GC cell lines, the Singapore dataset and The Cancer Genome Atlas (TCGA) dataset. We assessed the clinicopathological significance of the gene expression using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and performed immunohistochemical analysis for the gene in our patient cohort. We also performed survival analyses of the gene in our patient cohort, the Singapore dataset and the GSE62254 datasets. Moreover, gene set enrichment analysis (GSEA) was performed using the Singapore and TCGA datasets. Finally, in vitro experiments such as invasion/migration assays, immunofluorescence staining of actin filaments, epidermal growth factor (EGF) treatment analysis, and gene expression analysis were conducted using three gene-knockdown GC cell lines (AGS, 58As9, MKN45). RESULTS: ADP-ribosylation factor-like 4c (ARL4C) was identified as a PD-associated gene, and immunohistochemical analysis showed that ARL4C was overexpressed in GC cells. High ARL4C expression was associated with the depth of invasion (p < 0.01) and PD (p < 0.05) and was a poor prognostic factor (p < 0.05) in our patient cohort, the Singapore dataset and the GSE62254 dataset. ARL4C expression positively correlated with the epithelial-mesenchymal transition (EMT) gene set in GSEA. Moreover, ARL4C knockdown reduced invasion/migration capacity, SLUG expression, and the formation of lamellipodia or filopodia in AGS and 58As9 cells. Finally, EGF treatment increased ARL4C expression in MKN45 cells. CONCLUSIONS:ARL4C was associated with PD and was a poor prognostic factor in GC, possibly through promoting invasive capacity by activation of both EMT and motility.続きを見る |
本文ファイル
| ファイル | ファイルタイプ | サイズ | 閲覧回数 | 説明 |
|---|---|---|---|---|
med3123_abstract
|
165 KB | 679 | 要旨 | |
|
med3123_summary
|
165 KB | 158 | 要約 | |
|
med3123_review
|
266 KB | 199 | 審査結果要旨 |
詳細
| レコードID | |
|---|---|
| 査読有無 | |
| 権利関係 | |
| 関連PubMed ID | |
| 報告番号 | |
| 学位記番号 | |
| 授与日(学位/助成/特許) | |
| 受理日 | |
| 部局 | |
| 登録日 | 2018.05.30 |
| 更新日 | 2018.08.31 |